Scott M. Lippman, M.D.: Short CV

Curriculum Vitae
Scott M. Lippman, M.D.
Page 12
as a marker of an early stage of carcinogenesis in the human tracheobronchial
epithelium. Int J Cancer 45:811-5, 1990.
35. Slymen DJ, Miller TP, Lippman SM, Spier CM, Kerrigan DP, Rybski JA,
Rangel CS, Richter LC, Grogan TM. Immunobiologic factors predictive of
clinical outcome in diffuse large cell lymphoma. J Clin Oncol 8:986-93, 1990.
36. Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK.
Biomarkers as intermediate endpoints in chemoprevention trials. J Natl Cancer
Inst 82:555-60, 1990.
37. Modiano MR, Dalton WS, Lippman SM, Joffe L, Booth AR, Meyskens FL Jr.
Ocular toxic effects of fenretinide. J Natl Cancer Inst 82:1063, 1990.
38. Hong WK, Lippman SM, Itri L, Karp DD, Lee JS, Byers RM, Schantz SP,
Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, Goepfert H.
Prevention of second primary tumors with isotretinoin in squamous cell
carcinoma of the head and neck. N Engl J Med 323:795-801, 1990.
39. Fossella FV, Lippman SM, Seitz DE, Alberts DS, Taylor CW, Wiltshaw E,
Hardy J, Obrien M, Haynes TR, Wolen RL. Hypoprothrombinemia from
coadministration of sulofenur (LY 186641) and warfarin: report of three cases.
Invest New Drugs 9:357-9, 1991.
40. Rybski JA, Spier CM, Miller TP, Lippman SM, McGee DL, Grogan TM.
Prediction of outcome in diffuse large cell lymphoma by the major
histocompatibility complex class I (HLA-A, B, C) and class II (HLA-DR, DP,
DQ) phenotype. Leukemia and Lymphoma 6:31-8, 1991.
41. Gordon PR, Bassford TL, Lippman SM. Cancer risk reduction counseling: a
computer-assisted curriculum. Am J Prev Med 7:244-7, 1991.
42. Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin
DM, Dimery IW, Glisson BS, Hong WK. Edatrexate improves the antitumor
effects of cyclophosphamide and cisplatin against non-small cell lung cancer.
Cancer 68:959-64, 1991.
43. Lippman SM, Bassford TL, Meyskens FL. A quantitatively scored cancer-risk
assessment tool: its development and use. J Cancer Educ 7:15-36, 1992.
44. Lippman SM, Parkinson DR, Itri L, Weber RS, Schantz SP, Ota DM,
Schusterman MA, Krakoff IH, Gutterman JU, Hong WK. 13-cis retinoic acid
plus interferon-α2a: effective therapy for advanced squamous cell carcinoma of
the skin. J Natl Cancer Inst 84:235-41, 1992.
45. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueno F,
Paredes-Casillas P, Hong WK, Holdener E, Krakoff IW. 13-cis retinoic acid plus
interferon-α2a: highly active systemic therapy for squamous cell carcinoma of
the cervix. J Natl Cancer Inst 84:241-5, 1992.
46. Benner SE, Lippman SM, Wargovich MJ, Velasco M, Peters EJ, Morice RC,
Hong WK. Micronuclei in bronchial biopsy specimens from heavy smokers:
characterization of an intermediate marker of lung carcinogenesis. Int J Cancer
52:44-7, 1992.